Healthcare & Life Sciences News and Articles

Google News – CDC External News

Early Release - Under the Iceberg - Volume 32, Supplement—September 2026 - Emerging Infectious Diseases journal - Centers for Disease Control and Prevention | CDC (.gov)

news.google.com · 10 Sep 2026

Google News – Pharmaceuticals External News

Veloxis Pharmaceuticals’ $46 Million Kickback Settlement: A CEP Case Study Worth Studying Closely - JD Supra

news.google.com · 10 Sep 2026

Google News – Pharmaceuticals External News

Rocket Pharmaceuticals (RCKT) Up 6% Since Last Earnings Report: Can It Continue? - Yahoo Finance

news.google.com · 09 Sep 2026

Industry News External News

WED Healthcare Report: Nurses at SSM Health St. Mary’s Hospital file charges with NLRB, union announces - WisBusiness

news.google.com · 09 Sep 2026

Industry News External News

Hartford HealthCare, Backus Hospital launch state’s first Mobile Integrated Health program - Hartford Business Journal

news.google.com · 09 Sep 2026

Google News – Oncology External News

Tyra rolls toward pivotal cancer study even as stock deflates - Fierce Biotech

news.google.com · 09 Sep 2026

Google News – Biopharma External News

Can-Fite Biopharma Reports Clinical Improvement with Namodenoson in Decompensated Cirrhosis and Successful Bridging to Liver Transplantation - marketscreener.com

news.google.com · 09 Sep 2026

Google News – Biopharma External News

Propanc Biopharma to Initiate World-First Phase 1b First-in-Human Study of PRP in February 2027 - marketscreener.com

news.google.com · 09 Sep 2026

Google News – Biopharma External News

A cancer treatment is planned for its first human study in 2027. Up to 50 patients could take part. - Stock Titan

news.google.com · 09 Sep 2026

Google News – Pharmaceuticals External News

Voyageur Pharmaceuticals Achieves First Milestone on Feasibility Study for Iodine Production; Secures USD $1 Million Payment - InvestorNews

news.google.com · 09 Sep 2026

Google News – Pharmaceuticals External News

Atmospheric NOₓ may contribute to NDSRI formation, study shows - europeanpharmaceuticalreview.com

news.google.com · 09 Sep 2026

Google News – Clinical Trials External News

Kazia Therapeutics Announces First Patient Dosed in PNOC035 Clinical Study Evaluating Paxalisib for Recurrent Pediatric AT/RT Brain Cancer - PR Newswire

news.google.com · 09 Sep 2026

Google News – Clinical Trials External News

Actuate Therapeutics Reports Synergistic Preclinical Activity of Elraglusib with RAS-Targeted Agents in Pancreatic Cancer Models - Quiver Quantitative

news.google.com · 09 Sep 2026

Google News – Oncology External News

Former Mural Oncology CEO launches new cancer biotech with $225M in venture capital - The Business Journals

news.google.com · 09 Sep 2026

Google News – Pharmaceuticals External News

Gilead launches research facility in US for new medicine development - Pharmaceutical Business review

news.google.com · 09 Sep 2026

News & Articles

The Frontline Signal: Turning Daily Friction Into Better Healthcare Hiring

The Digital Health Interpreter: Making Technology Usable in Care

The Pitt is up for 25 Emmys - but the show's biggest fans are real-life doctors

From Roster to Resilience: Building a Workforce Risk Register

The Protocol-to-Workflow Specialist: A Career Emerging in Clinical Research

Jury should decide if university’s hiring process was tainted by diversity goals, court rules

Running costs of vaccine damage scheme more than double amount paid to victims

CMS expands TAVR Medicare coverage to asymptomatic patients

Stryker stock falls on slower peripheral vascular, hip sales

Veterans Affairs taps Amwell for telehealth revamp - Healthcare Dive

8 stories on the healthcare affordability crunch

Campaigners hold vigil as stroke unit closes

Epidural Kit Correction: Medical Action Industries Issues Correction for Epidural Kits Containing Spectra Medical Devices Lidocaine Ampules

UK needs new laws for AI in healthcare, says watchdog

Migraines and acne among five more conditions pharmacists can treat

Maternal Mental Health Policy

4 questions about the FDA’s approach to generative AI

Presidential dialogue on high-threat pathogens

5 takeaways from Oura’s IPO filing

Contractors will bear repair costs for lift defects at Queen Mary Hospital, Hong Kong development chief says

Early Release - Under the Iceberg - Volume 32, Supplement—September 2026 - Emerging Infectious Diseases journal - Centers for Disease Control and Prevention | CDC (.gov)

Veloxis Pharmaceuticals’ $46 Million Kickback Settlement: A CEP Case Study Worth Studying Closely - JD Supra

Rocket Pharmaceuticals (RCKT) Up 6% Since Last Earnings Report: Can It Continue? - Yahoo Finance

WED Healthcare Report: Nurses at SSM Health St. Mary’s Hospital file charges with NLRB, union announces - WisBusiness

Hartford HealthCare, Backus Hospital launch state’s first Mobile Integrated Health program - Hartford Business Journal

Tyra rolls toward pivotal cancer study even as stock deflates - Fierce Biotech

Can-Fite Biopharma Reports Clinical Improvement with Namodenoson in Decompensated Cirrhosis and Successful Bridging to Liver Transplantation - marketscreener.com

Propanc Biopharma to Initiate World-First Phase 1b First-in-Human Study of PRP in February 2027 - marketscreener.com

A cancer treatment is planned for its first human study in 2027. Up to 50 patients could take part. - Stock Titan

Voyageur Pharmaceuticals Achieves First Milestone on Feasibility Study for Iodine Production; Secures USD $1 Million Payment - InvestorNews

Atmospheric NOₓ may contribute to NDSRI formation, study shows - europeanpharmaceuticalreview.com

Kazia Therapeutics Announces First Patient Dosed in PNOC035 Clinical Study Evaluating Paxalisib for Recurrent Pediatric AT/RT Brain Cancer - PR Newswire

Actuate Therapeutics Reports Synergistic Preclinical Activity of Elraglusib with RAS-Targeted Agents in Pancreatic Cancer Models - Quiver Quantitative

Former Mural Oncology CEO launches new cancer biotech with $225M in venture capital - The Business Journals

Gilead launches research facility in US for new medicine development - Pharmaceutical Business review